# A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

> **NCT00743470** · PHASE1 · TERMINATED · sponsor: **Abbott** · enrollment: 15 (actual)

## Conditions studied

- HIV
- Tuberculosis

## Interventions

- **DRUG:** lopinavir/ritonavir
- **DRUG:** rifabutin

## Key facts

- **NCT ID:** NCT00743470
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2010-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00743470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00743470, "A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00743470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*